Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Dalfampridine
Medication labelDalfampridine extended-release tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This…
Why this: Advisory · dailymed-prescription
Dalfampridine extended-release tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed [see Clinical Studies (14)].
- generic_name
- dalfampridine
- product_names
- Dalfampridine
- ndc
- 51407-876, 67877-444, 51407-876-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en